Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model
Recruiting
Observational Study
Inflammatory Bowel Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Inotrem · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
TIME is an observational study performed on UC and CD patients under endoscopic surveillance for monitoring the clinical activity of their disease. The main objective of the study is to confirm the therapeutic potential of TREM-1 in inflammatory bowel disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients between 18 and 60 years
* Signed informed consent
* Ulcerative colitis (UC) patients with active disease
* Crohn's disease (CD) patients with active disease
Exclusion Criteria:
* UC or CD patients in remission
* Patients between 18 and 60 years without informed cons…
Contacts
No contact information available.